Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FV057
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,199
Award facts
- Contract value 100% obligated
- $49,199.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $49.2K to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. This is a firm fixed price, non-set-aside contract with a completion date of December 30, 2025, issued on December 29, 2025. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling and runs through December 2026, positioning the company as a critical pharmaceutical and medical device supplier to military and federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a primary vendor for federal medical procurement across the Department of Defense and related agencies. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. This particular delivery order for diabetes management products reflects AmerisourceBergen's role in supplying specialized medical technologies to federal beneficiaries, consistent with the DLA's broader mission to equip military and veteran healthcare systems with essential pharmaceutical and medical products.
Quick answers
Who was awarded contract SPE2DR26FV057?
SPE2DR26FV057 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FV057 worth?
The government has obligated $49,199 on SPE2DR26FV057.
Is contract SPE2DR26FV057 an order under another contract?
Yes. SPE2DR26FV057 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV057 competed?
The extent of competition for SPE2DR26FV057 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award